ReviewThe Medical clinics of North America2018
Sleep Management Among Patients with Substance Use Disorders.
Review in The Medical clinics of North America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05588726 (Behavioral Intervention to Improve Insomnia Symptoms in Patients With Opioid Use Disorder), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Behavioral Intervention to Improve Insomnia Symptoms in Patients With Opioid Use Disorder
Who cites it
49 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.
- International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders.Frontiers in psychiatry · 2021Pooled it
- A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults.Journal of substance abuse treatment · 2021Trial
- Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors.Journal of clinical psychopharmacologyTrial
- Article
- Associations of cannabis, alcohol, and tobacco use combinations with sleep health.Addictive behaviors reports · 2026Article
- Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population.Sleep & breathing = Schlaf & Atmung · 2026Article
- Insomnia in stimulant use disorders: Prevalence and associations with negative affect.Sleep medicine · 2026Article
- Actigraphy-based sleep outcomes in substance use disorders: A protocol for a systematic review and meta-analysis.PloS one · 2026Article
- Nighttime Sleep Symptoms and Sleep-Relevant Medication Documentation Among Adults Receiving Buprenorphine for Opioid Use Disorder.Substance abuse and rehabilitation · 2026Article
- Sleep alterations in substance use disorders: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
- Sleep disruption, stress, and craving during inpatient treatment for opioid use disorder.Addictive behaviors · 2025Article
- Evidence of a relationship between circulating ghrelin and sleep quality in male alcohol-dependent patients after abstinence.BMC psychiatry · 2025Article
- Sleep disturbances relate to problematic alcohol use via effortful control and negative emotionality.Alcohol, clinical & experimental research · 2025Article
- Sleep and Substance Use: Exploring Reciprocal Impacts and Therapeutic Approaches.Current psychiatry reports · 2025Review
- A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Behavioral dysregulation at work: A moderated mediation analysis of sleep impairment, work-related stress, and substance use.AIMS public health · 2025Article
- Mental health, substance use, and a composite of sleep health in adults, 2018 Ohio behavioral risk factor surveillance system.Sleep medicine · 2024Article
- Nationally Representative Rates of Incident Prescription Opioid Use Among United States Adults and Selected Subpopulations: Longitudinal Cohort Study From the National Health Interview Survey, 2019 to 2020.The journal of pain · 2024Article
- "It's all connected:" A mixed methods study of insomnia, stigma, and discrimination among individuals on medication for opioid use disorder.Sleep health · 2024Article
- IUPHAR Review: New strategies for medications to treat substance use disorders.Pharmacological research · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
Sleep and substance use disorders commonly co-occur. Insomnia is commonly associated with use and withdrawal from substances. Circadian rhythm abnormalities are being increasingly linked with psychoactive substance use. Other sleep disorders, such as sleep-related breathing disorder, should be considered in the differential diagnosis of insomnia, especially in those with opioid use or alcohol use disorder. Insomnia that is brief or occurs in the context of active substance use is best treated by promoting abstinence. A referral to a sleep medicine clinic should be considered for those with chronic insomnia or when another intrinsic sleep disorder is suspected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.